Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalya V Guseva

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 4, 2016
Struma Ovarii With Malignant Transformation and Germline KIT Mutation: A Case Report With Review of the LiteratureDeqin Ma, Natalya V Guseva, Laila Dahmoush, et al.
Journal of Visualized Experiments : Jove|November 5, 2019
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene SequencingShailesh K Shahi, Kasra Zarei, Natalya V Guseva, et al.
Cold Spring Harbor Molecular Case Studies|April 24, 2019
Urothelial carcinoma with an <i>NRF1-BRAF</i> rearrangement and response to targeted therapyAlexandra L Isaacson, Natalya V Guseva, Aaron D Bossler, et al.
The Prostate|May 3, 2002
Contribution of death receptor and mitochondrial pathways to Fas-mediated apoptosis in the prostatic carcinoma cell line PC3Natalya V Guseva, Agshin F Taghiyev, Oskar W Rokhlin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2008
Characterization of murine cytomegalovirus m157 from infected cells and identification of critical residues mediating recognition by the NK cell receptor Ly49HAja H Davis, Natalya V Guseva, Brianne L Ball, et al.
Journal of Cellular Biochemistry|December 23, 2003
Death receptor-induced cell death in prostate cancerNatalya V Guseva, Agshin F Taghiyev, Oskar W Rokhlin, et al.
Breast Cancer Research and Treatment|April 25, 2007
Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L)Natalya V Guseva, Oskar W Rokhlin, Agshin F Taghiyev, et al.
Cancer Biology & Therapy|March 13, 2012
P53 and the proteasome regulate androgen receptor activityNatalya V Guseva, Oskar W Rokhlin, Rebecca A Glover, et al.
Cancer Biology & Therapy|April 29, 2011
TOFA (5-tetradecyl-oxy-2-furoic acid) reduces fatty acid synthesis, inhibits expression of AR, neuropilin-1 and Mcl-1 and kills prostate cancer cells independent of p53 statusNatalya V Guseva, Oskar W Rokhlin, Rebecca A Glover, et al.
Frontiers in Oncology|June 7, 2023
Ramakrishna R Sompallae, Bilge Dundar, Natalya V Guseva, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 4, 2016
Struma Ovarii With Malignant Transformation and Germline KIT Mutation: A Case Report With Review of the LiteratureDeqin Ma, Natalya V Guseva, Laila Dahmoush, et al.
Journal of Visualized Experiments : Jove|November 5, 2019
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene SequencingShailesh K Shahi, Kasra Zarei, Natalya V Guseva, et al.
Cold Spring Harbor Molecular Case Studies|April 24, 2019
Urothelial carcinoma with an <i>NRF1-BRAF</i> rearrangement and response to targeted therapyAlexandra L Isaacson, Natalya V Guseva, Aaron D Bossler, et al.
The Prostate|May 3, 2002
Contribution of death receptor and mitochondrial pathways to Fas-mediated apoptosis in the prostatic carcinoma cell line PC3Natalya V Guseva, Agshin F Taghiyev, Oskar W Rokhlin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2008
Characterization of murine cytomegalovirus m157 from infected cells and identification of critical residues mediating recognition by the NK cell receptor Ly49HAja H Davis, Natalya V Guseva, Brianne L Ball, et al.
Journal of Cellular Biochemistry|December 23, 2003
Death receptor-induced cell death in prostate cancerNatalya V Guseva, Agshin F Taghiyev, Oskar W Rokhlin, et al.
Breast Cancer Research and Treatment|April 25, 2007
Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L)Natalya V Guseva, Oskar W Rokhlin, Agshin F Taghiyev, et al.
Cancer Biology & Therapy|March 13, 2012
P53 and the proteasome regulate androgen receptor activityNatalya V Guseva, Oskar W Rokhlin, Rebecca A Glover, et al.
Cancer Biology & Therapy|April 29, 2011
TOFA (5-tetradecyl-oxy-2-furoic acid) reduces fatty acid synthesis, inhibits expression of AR, neuropilin-1 and Mcl-1 and kills prostate cancer cells independent of p53 statusNatalya V Guseva, Oskar W Rokhlin, Rebecca A Glover, et al.
Frontiers in Oncology|June 7, 2023
Ramakrishna R Sompallae, Bilge Dundar, Natalya V Guseva, et al.
Pageof 3